Reshma P. Shetty, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 112,950 shares at $1.84 ($203K) on 2023-09-20, disclosed to the SEC on 2023-09-22.
Scheduled sale ($203k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.84 | 37,650 | $69K | 34.2% |
| 2 | $1.77 | 37,650 | $67K | 32.9% |
| 3 | $1.77 | 37,650 | $67K | 32.9% |
| Total | $1.79 avg | 112,950 | $203K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |